Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
26.58
+2.68 (11.21%)
At close: Aug 13, 2025, 4:00 PM
26.60
+0.02 (0.08%)
After-hours: Aug 13, 2025, 7:55 PM EDT
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $3.36 billion as of August 13, 2025. Its market cap has decreased by -29.59% in one year.
Market Cap
3.36B
Enterprise Value
3.45B
1-Year Change
-29.59%
Ranking
Category
Stock Price
$26.58
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.07M to $3.36B, an increase of 385.73%. That is a compound annual growth rate of 22.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 574.04B |
Johnson & Johnson | 416.11B |
AbbVie | 350.91B |
UnitedHealth Group | 236.90B |
AstraZeneca | 232.33B |
Novartis AG | 230.64B |
Abbott Laboratories | 228.03B |
Novo Nordisk | 223.00B |